The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 25th 2024
Findings highlight the unmet medical need for outpatient interventions and preventive measures that can reduce hospitalizations.
This World Standards Week, USP Sheds Light on Key Shifts in Standards Development
October 25th 2021World Standards Week is October 25 to 29, so Pharmacy Times interviewed Jaap Venema, PhD, EVP and CSO at USP, on some of the key shifts that have occurred in USP’s standards development during the COVID-19 pandemic.
Watch
FDA Approves Dupilumab for Children Aged 6 to 11 With Moderate to Severe Asthma
October 21st 2021The approval is based on data from a phase 3 placebo-controlled trial that evaluated the efficacy and safety of dupilumab combined with standard-of-care therapy in children with uncontrolled moderate-to-severe asthma.
Read More
Blockchain Has Potential For the Future of Personal Health Records, Electronic Health Records
October 21st 2021While Bitcoin and Ethereum garner most of the attention in the cryptocurrency space, there are a number of opportunities present for implementing blockchain into global health technology, with perhaps one of the most intuitive being its potential as a platform for health records.
Read More
Potential Drug-Drug Interactions With Psilocybin, MDMA, Ketamine
October 21st 2021Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses potential drug-drug interactions with psilocybin, MDMA, and ketamine to consider outside of interactions with psychiatric medications.
Watch
FDA Approves Seglentis for Acute Pain Management
October 21st 2021Celecoxib and tramadol hydrochloride (Seglentis; Esteve Pharmaceuticals) is an oral prescription with a unique co-crystal formulation of the anti-inflammatory drug, celecoxib, and the schedule IV opioid analgesic drug, tramadol.
Read More